3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
6
Colorectal Neoplasms
2
PIK3CA-Mutated Cancers
1
Neoplasm Metastasis
1
Metastatic Castration-Resistant Prostate Cancer
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
enzalutamide
2
inavolisib
1
abiraterone
1
PF06821497
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Metastatic Castration-Resistant Prostate Cancer
×
inavolisib
×
30 days
×
Clear all
NCT07287150
2026-06-04
InavoPC
Hoffmann-La Roche
Phase 2
Recruiting
100 enrolled